Cited by 68Cervical Cancer and HPV ResearchHead and Neck Cancer StudiesGenital Health and Disease

Prevalence of human papillomavirus types in cervical and oral cancers in central India

Gheit, Tarik, Vaccarella, Salvatore, Schmitt, Markus, Pawlita, Michael, Franceschi, Silvia, Sankaranarayanan, Rengaswamy, Sylla, Bakary S., Tommasino, Massimo +1 more·2009·Vaccine

Abstract

Cervical cancer that is associated with high-risk human papillomaviruses (HPV) is the most common malignancy in Indian women. Therefore, the establishment of a prevention program is urgently required considering both vaccination and screening. However, relatively little is known about the prevalence of the different HPV types in cervical cancers in different regions of India, particularly central India. In this study, we have determined the HPV type distribution in 180 cervical cancers of women from Sevagram, a rural area from central India. In addition, we have analyzed other epithelial cancers that are known to be in part associated with high-risk HPV infection, i.e. oral (n=65), vulva and vagina (n=7) and penis (n=7). Approximately 93% of cervical cancers were positive for one or more of the high-risk HPV types. HPV16 was the predominant type being present in 81.7% of the cases. The remaining most predominant high-risk HPV types were: 18, 31, 35, 45, 56 and 59. Oral and vulva/vagina cancers were exclusively associated with HPV16, 27.7% and 70%, respectively. None of penile cancers was found positive for any of the high-risk HPV types. These data show that HPV16 vaccination in this geographical region will have considerable impact on the prevention of cervical and other epithelial cancers.

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2008.11.041

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gheit, T., Vaccarella, S., Schmitt, M., Pawlita, M., Franceschi, S., Sankaranarayanan, R., Sylla, B. S., Tommasino, M., & Gangane, N.
Affiliations
  • Centre international de recherche sur le cancer (FR)
  • German Cancer Research Center (DE)
  • Mahatma Gandhi Institute of Medical Sciences (IN)
Corresponding author
Tommasino, Massimo
Venue
Vaccine
Publisher
Elsevier BV
Published
2009-01
Volume
27
Issue
5
Pages
636-639
ISSN
0264-410X (ISSN-L)
OpenAlex
W1967878457
Cited by
68
References
1
Citations by year
2026: 1 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 2 · 2021: 5 · 2020: 6 · 2018: 3 · 2017: 8 · 2016: 2 · 2015: 7 · 2014: 3 · 2013: 4 · 2012: 3
FWCI
1.24
Type
journal article
Language
en
Open access
closed
Locations
  • Vaccine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Association pour la Recherche sur le Cancer
  • Ligue Contre le Cancer
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
  • Health Sciences › Medicine › Surgery › Genital Health and Disease
Keywords
human papillomavirus, HPV genotype distribution, cervical cancer, oral cancer, vulvar cancer, vaginal cancer, penile cancer, HPV16, high-risk HPV, HPV vaccination, cancer prevention, rural women, Central India
MeSH terms
Adult, Aged, Aged, 80 and over, Uterine Cervical Neoplasms, Female, Genotype, Humans, India, Male, Middle Aged, Mouth Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Prevalence, Papillomaviridae, Papillomavirus Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review